BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Prognosis
16 results:

  • 1. Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction.
    Zhang C; Shen C
    Medicine (Baltimore); 2023 Nov; 102(45):e35881. PubMed ID: 37960805
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk factors of local recurrence following implant-based breast reconstruction in breast cancer patients.
    Fujihara M; Yamasaki R; Ito M; Shien T; Maeda R; Kin T; Ueno A; Kajiwara Y; Kawasaki K; Ichimura K; Mihara H; Kimura N; Ohtani S
    BMC Womens Health; 2021 Apr; 21(1):147. PubMed ID: 33838670
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ROCK1 and ROCK2 Are Down-regulated in Aggressive and Advanced skin Melanomas - A Clinicopathological Perspective.
    Kaczorowski M; Biecek P; Donizy P; Pieniążek M; Matkowski R; Hałoń A
    Anticancer Res; 2020 Apr; 40(4):1931-1942. PubMed ID: 32234882
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study.
    Tsutsui K; Takahashi A; Muto Y; Mizuta H; Jinnai S; Nakama K; Ogata D; Namikawa K; Yamazaki N
    J Dermatol; 2020 May; 47(5):512-517. PubMed ID: 32157716
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03).
    Faivre JC; Peiffert D; Vendrely V; Lemanski C; Hannoun-Levi JM; Mirabel X; Stanbury T; Salleron J; Guillemin F
    Radiother Oncol; 2018 Dec; 129(3):463-470. PubMed ID: 30172453
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
    Copson ER; Maishman TC; Tapper WJ; Cutress RI; Greville-Heygate S; Altman DG; Eccles B; Gerty S; Durcan LT; Jones L; Evans DG; Thompson AM; Pharoah P; Easton DF; Dunning AM; Hanby A; Lakhani S; Eeles R; Gilbert FJ; Hamed H; Hodgson S; Simmonds P; Stanton L; Eccles DM
    Lancet Oncol; 2018 Feb; 19(2):169-180. PubMed ID: 29337092
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Down-regulated miR-23a Contributes to the Metastasis of Cutaneous Melanoma by Promoting Autophagy.
    Guo W; Wang H; Yang Y; Guo S; Zhang W; Liu Y; Yi X; Ma J; Zhao T; Liu L; Jian Z; Liu L; Wang G; Gao T; Shi Q; Li C
    Theranostics; 2017; 7(8):2231-2249. PubMed ID: 28740547
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. miR-194 is a negative regulator of GEF-H1 pathway in melanoma.
    Guo B; Hui Q; Zhang Y; Chang P; Tao K
    Oncol Rep; 2016 Oct; 36(4):2412-20. PubMed ID: 27573550
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.
    Pasquali S; Mocellin S; Mozzillo N; Maurichi A; Quaglino P; Borgognoni L; Solari N; Piazzalunga D; Mascheroni L; Giudice G; Patuzzo R; Caracò C; Ribero S; Marone U; Santinami M; Rossi CR
    J Clin Oncol; 2014 Mar; 32(9):935-41. PubMed ID: 24516022
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.
    Wang E; Zhao Y; Monaco A; Uccellini L; Kirkwood JM; Spyropoulou-Vlachou M; Panelli MC; Marincola FM; Gogas H
    PLoS One; 2012; 7(7):e40805. PubMed ID: 22911710
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Diffuse neonatal hemangiomatosis: an evidence-based review of case reports in the literature.
    Glick ZR; Frieden IJ; Garzon MC; Mully TW; Drolet BA
    J Am Acad Dermatol; 2012 Nov; 67(5):898-903. PubMed ID: 22341467
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions.
    Klein RM; Aplin AE
    Cancer Res; 2009 Mar; 69(6):2224-33. PubMed ID: 19244113
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Role of ING4 in human melanoma cell migration, invasion and patient survival.
    Li J; Martinka M; Li G
    Carcinogenesis; 2008 Jul; 29(7):1373-9. PubMed ID: 18375955
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration.
    Gao K; Dai DL; Martinka M; Li G
    Cancer Res; 2006 Sep; 66(17):8382-8. PubMed ID: 16951147
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
    Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
    J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Survival of cutaneous malignant melanoma patients at University of Iowa Hospitals: 1950--1974.
    Griffel M
    Cancer; 1981 Jan; 47(1):176-83. PubMed ID: 7459806
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.